A Study to Evaluate the Efficacy of Investigational OTC Eye Drops

Ophthalmic Solutions Clinical Trial

Official title:
A Single-Center, Randomized, Controlled Study to Evaluate the Efficacy of Two Investigational OTC Eye Drops in Healthy Adults With Red Eye

Status Completed

Clinical Trial Summary

This is a single center, double-blinded study designed to demonstrate the therapeutic equivalence of over-the-counter eye drops in healthy adults with red eyes.

Clinical Trial Description

Eligible participants will use assigned eye drop products as directed. Participants will be required to attend 2 consecutive clinic visits. Assessments for eye redness and eye comfort will be completed. Participants will complete brief questionnaires about their eyes. ;

Study Design

Related Conditions & MeSH terms

Ophthalmic Solutions

Clinical Trial Details

NCT number	NCT03198000
Study type	Interventional
Source	Johnson & Johnson Consumer and Personal Products Worldwide
Contact
Status	Completed
Phase	Phase 3
Start date	June 28, 2017
Completion date	July 21, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02697318` - Evaluation of a New Method for Instilling Eye Drops	Early Phase 1
Completed	`NCT05936489` - Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia	Phase 1
Terminated	`NCT03591874` - Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease	Phase 3